MSCCOP

		home :: clinical trials :: treatment trials :: clinical trials

		CLINICAL TRIALS

AVAILABLE CLINICAL TRIALS

Cancer Control/Prevention Clinical Trials
	Ref #	Title
Stage 0-IIIA	CCCWFU 97609	GENETIC SUSCEPTIBILITY TO RADIATION-INDUCED SKIN REACTIONS IN RACIAL/ETHNIC GROUPS OF PATIENTS WITH BREAST CANCER
HER2 (+)	SCUSF 0806	PLACEBO-CONTROLLED TRIAL OF LISINOPRIL AND COREG CR® TO REDUCE CARDIOTOXICITY IN PATIENTS WITH BREAST CANCER RECEIVING (NEO)ADJUVANT CHEMOTHERAPY WITH TRASTUZUMAB (HERCEPTIN®)
Resected Colon/Stage I or II	NSABP P-5	STATIN POLYP PREVENTION TRIAL IN PATIENTS WITH RESECTED COLON CANCER
Breast	CALGB 70806	VITAMIN D AND BREAST CANCER BIOMARKERS
Her2(+)	NSABP B-43	A PHASE III CLINICAL TRIAL COMPARING TRASTUZUMAB GIVEN CONCURRENTLY WITH RADIATION THERAPY AND RADIATION THERAPY ALONE FOR WOMEN WITH HER2-POSITIVE DUCTAL CARCINOMA IN SITU RESECTED BY LUMPECTOMY
Lymphedema Stage I,II, or III	CALGB 70305	STUDY TO PREVENT LYMPHEDEMA IN WOMEN TREATED FOR BREAST CANCER